Papers
2
Total Citations
26
H-Index
2
About
Dr. Pu Li is a urologic oncologist whose research focuses on advancing the surgical and diagnostic management of kidney and prostate cancers. In a landmark 2014 systematic review and meta-analysis, Dr. Li compared radiofrequency ablation with partial nephrectomy for clinical stage 1 renal masses, providing critical evidence on the efficacy and safety of these minimally invasive treatments for small renal tumors. This highly cited work (22 citations) has helped shape clinical decision-making in the era of increasing small renal mass diagnoses. More recently, Dr. Li has contributed to the understanding of rare and aggressive malignancies, authoring a single-center study on primary prostatic signet ring cell carcinoma (PPSRCC). This work, drawing on experience at the First Affiliated Hospital of Nanjing Medical University, offers valuable insights into the diagnosis and management of this challenging disease. Through these contributions, Dr. Li has demonstrated a commitment to improving patient outcomes by evaluating novel treatment paradigms and characterizing uncommon urologic cancers, solidifying their role as a thoughtful contributor to the field of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2